Introduction
Clinical observations indicate that systemically administered morphine and other opiates selectively attenuate sensations evoked by noxious, but not innocuous stimuli (Behar et al., 1979; Wang et al., 1979) . Opiates can act at both spinal and supraspinal sites to reduce neuronal responsiveness to nociceptive stimuli (see Duggan & North, 1984, for review) . Intrathecal administration of opiates or opioid peptides can elicit behavioural analgesia in man and animals (Wang et al., 1979; Onofrio & Yaksh, 1983;  Yaksh, 1983; Schmauss & Yaksh, 1984) . Behavioural studies have suggested the efficacy of intrathecally administered opioids at both a- (Schmauss & Yaksh, 1984) and 6-sites (Hill et al., 1987) . Systemic and intrathecal administration of K-agonists have been reported as antinociceptive, particularly in visceral and mechanical nociceptive tests (Hayes et al., 1983; Schmauss & Yaksh, 1984) . Other groups have observed thermal antinociception with intrathecal dynorphins and U50488H although there appears to be little margin between antinociception and motor dysfunction and paralysis (see Fleetwood-Walker, 1988; Millan, 1990 , for reviews). The presence of these receptor subtypes and endogenous opioid peptides within the dorsal horn of the spinal cord, especially the superficial laminae (Hokfelt et al., 1977; Botticelli et al., 1981; Morris & Herz, 1987; Mansour et al., 1988) suggests a complex role for opioids in influencing the spinal processing of nociceptive information at the single neurone level. Although the CNS of the rat contains relatively low levels of K receptors (Mansour et al., 1988) their presence in dorsal horn, especially the superficial zone is now wellestablished (Morris & Herz, 1987) .
In electrophysiological studies, single neurones of the dorsal horn in lamina I, lamina II (the substantia gelatinosa) or in the deeper dorsal horn (laminae III-V) exhibit somewhat different functional characteristics (Menetrey et al., 1977; Cervero & Iggo, 1980; McMahon & Wall, 1983 ; Schouenborg 1 Author for correspondence. & Sjolund, 1983 ) including a range of responses to noxious and/or innocuous cutaneous stimuli. The effects of microionophoretically-applied opioids (including morphine) on single dorsal horn neurones have been investigated by a number of groups (Calvillo et al., 1974; Dostrovsky & Pomeranz, 1976; Zieglgansberger & Bayerl, 1976; Duggan et al., 1977; Belcher & Ryall, 1978; Davies & Dray, 1978; Piercey et al., 1980) . In general, either depression or excitation of multireceptive neurones in the deeper dorsal horn was reported. These effects were rarely reversible by naloxone. In contrast, more consistent antinociceptive and naloxonereversible effects were observed with deeper dorsal horn neurones when opiates were administered into the substantia gelatinosa (lamina II) (Duggan et al., 1977; Sastry & Goh, 1983) . These results indicated that the effects of agonists at different opioid receptors may be rather discretely mediated within distinct laminae of the dorsal horn.
A recent study from our laboratory supported this hypothesis. Fleetwood-Walker et al. (1988) reported that when administered near to spinocervical tract (SCT) neurones in laminae HII-V of cat spinal cord, only K agonists exerted a selective antinociceptive action whilst p and 6 agonists were ineffective. In contrast, A, but not 6 or K agonists ionophoretically applied in the region of the substantia gelatinosa had a selective antinociceptive effect on SCT neurones. In these experiments there was little evidence for any significant antinociceptive role of 6 agonists at either of these two loci. However, results of intrathecal studies showed that 6, as well as u and K, agonists have distinct analgesic actions (Onofrio & Yaksh, 1983; Hill et al., 1987) . Whilst the effects of receptor-selective opioid agonists administered in lamina II and laminae III-V were investigated in detail by Fleetwood-Walker et al. (1988) Ltd, 1990 appeared in abstract form (Fleetwood-Walker et al., 1986; Hope et al., 1987) .
Methods
Experiments were carried out on rats (270-330g) anaesthetized with intravenous a-chloralose (35mg kg-1) and urethane (700mgkg-1), after induction with halothane. Supplementary doses of anaesthetic were given as required. Core temperature was maintained at 37-380C and carotid blood pressure was monitored throughout the experiment. If blood presure fell below 90mmHg, the experiment was terminated. Humidified oxygen (0.11 min -1) was passed through one arm of a patent Y-shaped cannula to enrich the inspired air of spontaneously respiring rats. A craniotomy was performed to allow sterotaxic placement of electrodes at supraspinal sites and a laminectomy (thoracic 12-lumbar 4) allowed access for electrophysiological recordings from dorsal horn neurones.
Electrophysiological methods
Extracellular recordings were made via the central barrel (4M NaCi, pH 4.0-4.5) of a 7 barrelled glass microelectrode. Electrode tip sizes were 4.0-4.5 um and d.c. resistances were 5-8 MO. The band-width of the recording amplifier was 1 Hz7kHz.
One side barrel contained 1 M NaCl (pH 4.0-4.5) for automatic current balancing and current controls (Neurophore Ionophoresis System, Medical Systems Corporation). Another side barrel contained Pontamine Sky Blue dye (2% in 0.5 M sodium acetate for marking recording sites by ejection for 50A min). Other barrels contained various opioid receptorselective agonists or antagonists (Corbett et al., 1984; Fleetwood-Walker et al., 1988) : 2.5 mm dynorphin A1-13
100mM naloxone hydrochloride, 30mM ICI 174864 (N,Ndiallyl-Tyr-Aib-Aib-Phe-Leu) (all in aqueous solution at pH 4.0-4.5), 5 mM U50488H (trans-3,4-dichloro-N-methyl-N{2-pyrrolidinyl)cyclohexyl-benzene acetamide, U50) in 100MM NaCl at pH 4.0-4.5 and 100mM D,L-homocysteic acid (DLH) and 100mM sodium glutamate in aqueous solution at pH 8.0-8.5. Synthetic peptides were obtained from Sigma or Cambridge Research Biochemicals, except for ICI 174864 which was a gift from ICI Pharmaceuticals plc.
All drugs were applied with a cathodal current except DLH and glutamate (anodal). Retention currents of 10-15 nA were applied to minimize drug leakage between tests.
The location of each neurone was examined histologically, having been marked by Pontamine Sky Blue dye ejection, at the end of each test. Many neurones located in lamina I were also identified as belonging to the spinomesencephalic tract (SMT) by use of standard antidromic criteria (Lipski, 1981) . Concentric bipolar electrodes (Rhodes Medical SNE-100) were stereotaxically placed in the region of the contralateral parabrachial nucleus (posterior 9.5-10.0mm, ventral 6.5-7.0mm and lateral 0.5-1.0mm, with respect to bregma (Hylden et al., 1986; Paxinos & Watson, 1986) . The positions of all stimulating electrodes were marked by iron deposition from the electrode (30-60s, 30pA d.c.) and verified histologically, following ferryocyanide staining.
Test protocols
Action protocols of the recorded neurones were of uniform size and shape and could be clearly discriminated from other field potentials. All dorsal horn neurones had cutaneous excitatory receptive fields on the ipsilateral hindlimb. The field properties were carefully examined by use of both noxious and innocuous cutaneous stimuli before and after testing with drugs. Neurones were selected that could be classified as either multireceptive or nocispecific. Multireceptive neurones responded to both innocuous stimuli (light brushing, gentle squeeze and/or tapping) and noxious stimuli (pinch and/or radiant heat, 46-49C). In contrast, nocispecific neurones responded only to noxious stimuli and gave no response to any innocuous stimuli tested. Having thus classified the receptive field of the neurone, cottrolled cutaneous stimuli were applied (usually for 10s periods) to adjacent cutaneous areas, within the receptive field. The innocuous stimulus used was a motorized rotating brush. Noxious stimuli were provided by a calibrated pinch (serrated forceps with a graduated controlled displacement) or a thermocouple-controlled radiant heat lamp (giving a surface temperature ramp between 30-490C). Responses to these stimuli and DLH-or glutamate-evoked activity (in response to ionophoresis at 5-60nA for 10-15s) were regularly repeated over 3 or 4min cycles. These responses were always submaximal and approximately matched in terms of neuronal firing rates. Duplicate or triplicate controls varied by less than 15%. Neuronal firing was recorded on FM tape and firing rates (400ms bins) were plotted on-line by computer (Cromemco System III), together with analogue signals from the stimulators and the ionophoresis unit. Responses to pinch, heat, brush, DLH or glutamate and epochs of spontaneous activity were integrated over appropriate time scales and normalized against control values meaned from the duplicate or triplicate pre-drug control responses. These normalized values were expressed graphically (see Figure 1 , for example) to facilitate comparisons of drug effects on different classes of evoked activity. All drugs were continuously ionophoresed for 1 min before and for the duration of the test cycle. Ionophoretic ejection was started at currents of 5 nA and was increased between each subsequent cycle of tests by 5, 10 or 20nA intervals until a distinct action of an opioid agonist was observed. Ionophoresis of agonists was then either terminated and testing continued until responses recovered to control levels or was maintained for testing of reversal by an opioid antagonist.
Results

Characteristics ofcells
The excitatory receptive fields of all neurones tested were carefully mapped and were always located on the ipsilateral hind paw or limb. Inhibitory or contralateral receptive fields were rarely seen and were not tested. Twenty-seven neurones were subsequently located in the region of lamina I. Responses were evoked by noxious heat (-), noxious pinch (0), innocuous brush (A) and D,L-homocysteic acid (DLH) (U). The presence of both [u-Ala2,MePhe4,Gly-ol]enkephalin (DAMGO) (b) and 6 [D-Pen2 u-Pen5]enkephalin (DPDPE) (c) agonists caused a profound selective inhibition of the nociceptive responses (n = 9 and 8 respectively), whilst innocuous and DLH-evoked responses were unaffected. In contrast the K-agonist, U50488H (US0) (a) had no effect on the evoked activity of these neurones (n = 4).
93 + 5% of controls in 7 + 2 min (n = 4). The action of DAMGO was reversed by naloxone (20-0nA) but not by a selective 6-antagonist, ICI 174864 (60-75 nA). In contrast, ICI 174864 (20-50nA) consistently reversed typical DPDPEmediated effects, as shown in Figure 2 . In the 4 cases of DAMGO action in which reversal was investigated, the substantial inhibition of nociceptive responses caused by 15-20nA DAMGO was reversed to 96 + 12% of controls (pinch) by 4 + 2 min of naloxone at 20-60 nA. Intravenous naloxone was not tested. The 6 antagonist, ICI 178864 was ineffective, with DAMGO-suppressed pinch responses remaining at 26 + 4% of controls despite ionophoresis of ICI 174864 at 60-75 nA for 4 + 1 min (n = 3). In contrast, the substantial inhibition of noxious pinch responses caused by 15-20 nA DPDPE was reversed to 84 + 6% of control responses by 20-50nA of ICI 174864 for 5 + 1 min (n = 4). In no case was there any effect of antagonists alone. In contrast to the selective antinociceptive effects evoked by ionophoresis of p and 6 agonists at low ejection currents (5-25 nA) on both SMT and unidentified revealed Pontamine Sky Blue dye spots located immediately dorsal to the substantia gelatinosa (lamina II). Six dye spots were located ventral to the substantia gelatinosa, revealing the loci of neurones in the deeper dorsal horn laminae III-V.
Excitatory neuronal responses were evoked from 12 of the neurones located in lamina I and 6 of the neurones in laminae III-V, by both noxious and innocuous cutaneous stimuli. These multireceptive lamina I neurones, including 4 SMT neurones, all responded to an unequivocally noxious pinch and 4 out of 6 cells tested also responded to noxious radiant heat (44-48°C). In all 6 deeper dorsal horn cells tested and 7 out of 12 lamina I cells the initial vigorous response evoked by innocuous stimulation could be subsequently maintained throughout the experiment. However, 5 out of 12 lamina I cells demonstrated a gradual adaptation to testing with the first two or three innocuous brush stimuli applied. Thereafter repeated brush-evoked responses were consistently maintained at a lower level without alteration of the stimulus, for the duration of the experiment. This characteristic adaptation to non-nociceptive stimuli was seen both in SMT neurones and in lamina I neurones unidentified in terms of their ascending projections. However, neither the nociceptive responses of any lamina I neurones nor any responses of neurones located in laminae III-V demonstrated this feature of adaptation to controlled cutaneous stimuli. In such cases, stimuli could be repeatedly evoked at 3 min intervals for over 2 h.
A variety of innocuous stimuli (including brushing, gentle squeeze or tap) completely failed to evoke any response from 15 out of 27 lamina I neurones, including 10 SMT neurones. These neurones, however, consistently responded to noxious cutaneous stimuli and were thus classifed as nocispecific.
Both nocispecific and multireceptive neurones in lamina I showed a characteristic lack or minimal level (< 2 Hz) of spontaneous background activity. These neuronal characteristics were seen in both SMT and other cells, K agonists (U50488H or DYNO) had no effect at either the same (5-25 nA) or much higher (up to 100nA) ejection currents, in 4 out of 5 neurones tested (Figure 1) such results were consistent with the overall conclusion that j and/or 6 agonists would suppress nociceptive inputs to any individual neurone, whereas K agonists were ineffective.
Effects ofopioids applied in the vicinity of nocispecific Responses were evoked by noxious heat (0), noxious pinch (0) and D,L-homocysteic acid (DLH) (U). In (a) are shown cases (n = 5) in which DPDPE inhibited only the nociceptive responses (DLH-evoked activity was unaffected). In some cells (n = 3) DPDPE had no effect on levels of any evoked activity (b) . However, the predominant action of DPDPE is shown in (c) (in a total of 7 out of 15 neurones tested) in which all types of evoked activity (including DLH) were inhibited to a similar degree.
SMT cells. In contrast to the consistent selective antinociceptive effects on multireceptive lamina I neurones described above, the 6 agonist DPDPE had 3 different actions on nocispecific celis (Table 1 and Figure 3 ). DPDPE selectively inhibited the nociceptive responses of 5 out of 15 neurones, whilst the DLH-evoked responses were unaffected, with ejection currents of up to 25 nA (Figure 3a) . In one neurone of this type for which recovery was closely examined, the substantial inhibition of nociceptive responses due to DPDPE was reversed to more than 90% of control levels 5min after, stopping ejection of DPDPE. With the same test protocol both the nociceptive and DLH-evoked responses were inhibited to a similar degree in 7 out of 15 cells (Table 1 and Figure  3c ). In the 3 of these neurones for which recovery was examined, the DPDPE-induced suppression of evoked responses had recovered to near control values [for example 102 + 12% (DLH) and 87 + 9% (pinch)] by 6 ± 1 min after stopping ejection of DPDPE. Both of these actions of DPDPE were reversed by ionophoresis of the 6 antagonist, ICI 174868 (20-70nA). In all 3 of the selectively affected neurones that were tested with the 6 antagonist (including 2 SMT cells), the substantial inhibitions of nociceptive responses caused by 10-15 nA DPDPE ( Figure 3a) were readily reversed by ICI 174864. Pinch responses, for example, were restored to 92 +9% of controls by 20-60nA ICI 174864 applied for 4 + 1 min (n = 3). In all 4 of the non-selectively affected neurones that were tested with the 6 antagonist (including 2 SMT cells), the effects of DPDPE were also readily reversed by ICI 174864. For example, the suppressed responses to DLH and to noxious pinch were reversed to 88 + 12% and 85 + 3% of controls by 30-70nA ICI 174864 applied for 5 1 min (n = 4). No effect of ICI 174864 alone was ever apparent.
DPDPE failed to alter the responses of the remaining 3 neurones at either similar (5-20nA) (Figure 3b ) or in 2 of these cases, even at much higher ejection currents (up to 100nA) (not shown). The K agonists U50488H and DYNO failed to cause any change in responses tested (5-15nA) (Figure 4) 
Discussion
A variety of antinociceptive actions are mediated by p, 6 and K opioid agonists. As in the cat (Fleetwood-Walker et al., 1988) , the antinociceptive action of K agonists was exerted here on both the thermal and mechanical nociceptive responses of laminae III-V neurones to an apparently similar degree. Systemic or intrathecal administration of selective K agonists are most effective against visceral and mechanical nociception (Hayes et al., 1983; Schmauss & Yaksh, 1984) but there is little margin between doses causing antinociception and motor dysfunction or paralysis (see Millan, 1990 for review). In the present study, the range over which opioids could act was considerably restricted by virtue of the experimental design, although some diffusion of ionophoresed drugs must occur. The excitatory effects observed by Knox & Dickenson (1987) may have involved actions of intrathecally administered K agonists at various sites remote to the dorsal horn neurone being recorded. In our studies, the sites mediating such excitation may have been beyond the reach of ionophoresed K agonists. Selective inhibition of nociceptive responses, without affecting innocuous, DLH-evoked or spontaneous activity, indicates that inhibitory influences may be exerted specifically on the nociceptive pathway, rather than generally on any polysynaptic input or directly on the neurones being tested, either in laminae III-V and lamina I. For example, K agonists may inhibit nociceptive transmission to the deeper dorsal horn neurone being tested, via a closely antecedent interneurone, rather than by action on the nociceptive afferent fibres which predominantly terminate in the superficial dorsal horn (Cervero & Iggo, 1980) . In the case of K agonists, these proposed interneurones are unlikely to be located as far dorsal as the region of the substantia gelatinosa, because FleetwoodWalker et al. (1988) reported that ionophoresis of K agonists there failed to influence neurones located in laminae III-V. Similarly, the quite different profiles of drug action when applied in superficial laminae rather than laminae III-V suggest that drugs did not readily diffuse between the two. The majority (but not all) of the K receptors are present in superficial laminae (Slater & Patel, 1983; Morris & Herz, 1987) as are the endogenous K agonists (Botticelli et al., 1981) .
At first sight there appears to be a mismatch between structure and function. However, the superficial dynorphin-related peptides may have other roles than the modulation of acute cutaneous nociceptive inputs surveyed in the present study.
In contrast to the lack of action in the vicinity of deeper dorsal horn neurones, p and 6 receptor selective agonists often had profound influences on both nocispecific and multireceptive lamina I neurones. Autoradiographic studies have revealed p opioid binding sites correspondingly concentrated in the superficial dorsal horn (laminae I and II) (Atweh & Kuhar, 1977; Traynor et al., 1982; Mack et al., 1984; Dash- , 1985; Morris & Herz, 1987) and u agonists can exert an antinociceptive influence on deeper dorsal horn neurones, via the substantia gelatinosa, in the cat (FleetwoodWalker et al., 1988) . It is possible that the actions of p agonists ionophoresed in the vicinity of lamina I neurones in this study may exert their influence either via lamina I or via the adjacent substantia gelatinosa. Diffusion over such short distances is very likely. Whether such actions are mediated by effects on primary afferent terminals (Lamotte et al., 1976; Fields et al., 1980) or interneurones of the substantia gelatinosa (Yoshimura & North, 1983) , is not clear. The non-selective effects described may be due to actions either on antecedent interneurones or afferent terminals, in both the nonnociceptive pathways, or directly on the neurone being tested.
A recent autoradiographic study by Morris & Herz (1987) found 6 binding sites restricted to lamina I of the dorsal horn of the rat. This evidence is in accordance with our findings that 6 agonists failed to influence somatosensory inputs to deeper dorsal horn neurones (laminae III-V) when either applied nearby these cells (in the rat, this study; in the cat, Fleetwood-Walker et al., 1988) or in the substantia gelatinosa dorsal to the cells being recorded (Fleetwood-Walker et al., 1988) . The use of the selective 5 antagonist, ICI 174864, confirmed the involvement of 6 receptors in the modulation of somatosensory inputs to both multireceptive and nocispecific neurones in lamina I. Although the terminal excitability of primary afferent A6-and C-fibres is reduced by opiate derivatives active at both p and 6 sites (Carstens et al., 1979; Hentall & Fields, 1983) there must be some differential action of , and 6 agonists to account for the different effects caused by DAMGO and DPDPE on nocispecific lamina I neurones. Whilst DAMGO consistently inhibited only nociceptive responses, leaving non-nociceptive activity unaffected in multireceptive and nocispecific cells, DPDPE also regularly caused inhibition of both noxious and DLH-evoked responses to nocispecific cells. It therefore seems that there is not an ubiquitous inhibitory mechanism mediated by 6-receptors. The variety of both selective and non-selective actions of 6 agonists indicates a complex and perhaps important role for 6-receptor sites, restricted to lamina I (Morris & Herz, 1987) in the modulation of nociceptive transmission through the superficial dorsal horn and on to supraspinal sites.
